---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-245181"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2026-05-28T20:05:17+00:00"
generated_at: "2026-05-28T21:21:21.199443+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Standard BioTools approves severance plans for CEO, CFO, and CBO through 2028

## Summary
- 2026 Severance Plan for CFO Alex Kim and CBO Sean Mackay: outside COC, 12 months salary, prorated bonus, COBRA subsidy, equity acceleration if terminated by Aug 27, 2026.
- During COC: non-CEOs receive 150% of salary plus target bonus lump sum, 18 months COBRA, and full equity vesting.
- CEO Michael Egholm covered under 2023 Severance Plan: outside COC, 200% salary over 24 months, 12 months COBRA, outplacement.
- During COC: CEO gets 250% of salary plus bonus lump sum, 30 months COBRA, and full equity vesting.
- 2026 Severance Plan supersedes the 2024 plan; both plans expire August 4, 2028.

## SEC filing metadata
- accession: 0001193125-26-245181
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2026-05-28T20:05:17+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000119312526245181/0001193125-26-245181-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000119312526245181/lab-20260521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-245181
- JSON: https://secwatch.observer/filing/0001193125-26-245181.json
- Plain text: https://secwatch.observer/filing/0001193125-26-245181.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.